Evidence map›Paper›PMID 41302645›Full record

ArticleInternational journal of environmental research and public health2025

Impact of Medications and Marijuana Use on Hyposalivation and Xerostomia in Adults.

Carter Gehlken, Moni Ahmadian, Neamat Hassan Abubakr

Abstract read
In one paragraph

Article in International journal of environmental research and public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carter GehlkenSchool of Dental Medicine, University of Nevada Las Vegas, Las Vegas, NV 89106, USA.
Moni AhmadianDepartment of Clinical Sciences, School of Dental Medicine, University of Nevada Las Vegas, Las Vegas, NV 89106, USA.ORCID 0009-0009-1456-1160
Neamat Hassan AbubakrDepartment of Biomedical Sciences, School of Dental Medicine, University of Nevada Las Vegas, Las Vegas, NV 89106, USA.ORCID 0000-0003-4170-1842

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND/

objectivesHyposalivation is a prevalent yet underrecognized factor contributing to oral health deterioration, often influenced by systemic disease, medication use, and recreational drug exposure. With rising use of mental health and cardiovascular medications, as well as increasing marijuana use among younger populations, there is a need to assess real-world data on xerostomia and hyposalivation prevalence and associated risk factors. This study aimed to evaluate the prevalence of hyposalivation and xerostomia, and its etiological associations among adult patients at the University of Nevada, Las Vegas (UNLV) School of Dental Medicine Clinics.

methodsA retrospective cohort study was conducted using electronic health record (EHR) data from 1600 randomly selected patients aged 30 years and older, treated between 1 January 2014, and 31 May 2023. Data on demographics, medical and social history, medication use, and oral health status were extracted. Hyposalivation was identified via chart review, and multivariate logistic regression was used to analyze associated risk factors.

resultsHyposalivation and xerostomia were identified in 705 patients (44.06%). Marijuana use was the strongest independent predictor across all age groups (RR = 3.10,

conclusionsHyposalivation and xerostomia are increasingly observed in younger adults, linked to pharmacological and behavioral factors.

Indexed as

Marijuana UseXerostomiaAdultAgedFemaleHumansMaleMiddle AgedPrevalenceRetrospective StudiesRisk Factorsdry mouthhyposalivationrecreational drugxerostomia

Identifiers

PMID41302645
PMCPMC12652768

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.